Call Us08045479576
Guaifenesin Powder

Guaifenesin Powder

550 INR/Kilograms

Product Details:

  • Molecular Formula C10H14O4
  • Molecular Weight 198.24 Grams (g)
  • Heavy Metal (%) NOT MORE THAN 0.0025%
  • Storage Keep away from moisture
  • EINECS No 202-222-5
  • Structural Formula C10H14O4
  • HS Code 29095090
  • Click to View more
X

Guaifenesin Powder Price And Quantity

  • 25 Kilograms
  • 550 INR/Kilograms
  • 25.00 - 50.00 INR/Kilograms

Guaifenesin Powder Product Specifications

  • 6-10
  • NOT MORE THAN 0.5%
  • 356.8 at 760 mmHg
  • Guaifenesin is used to treat coughs and congestion caused by the common cold, bronchitis, and other breathing illnesses. This product is usually not used for ongoing cough from smoking or long-term breathing problems (such as chronic bronchitis, emphysema) unless directed by your doctor. Guaifenesin is an expectorant.
  • 93-14-1
  • Odorless
  • 3-10 um
  • White Solid
  • Powder
  • Other
  • 77-81
  • 1-5 Years
  • Guaiacol glyceryl ether
  • soluble in water
  • 29095090
  • C10H14O4
  • 202-222-5
  • Keep away from moisture
  • Medicine Grade
  • NOT MORE THAN 0.0025%
  • 98%
  • 198.24 Grams (g)
  • Pharmaceutical Intermediates
  • C10H14O4

Guaifenesin Powder Trade Information

  • ANY INDIAN PORT
  • Cash Against Delivery (CAD) Letter of Credit at Sight (Sight L/C) Letter of Credit (L/C) Cash in Advance (CID) Cash Advance (CA)
  • 1000 Kilograms Per Week
  • 7 Days
  • Yes
  • Free samples are available
  • DRUM PACK
  • Middle East Western Europe Africa Eastern Europe South America Asia Central America North America Australia
  • All India
  • ISO /GMP

Product Description

Guaifenesin Properties:

  • Synonyms: 3-(o-Methoxyphenoxy)-1,2-propanediol, Glycerol guaiacolate, Guaiacol glyceryl ether
  • CAS Number: 93-14-1
  • Molecular Formula: C10H14O4
  • Molecular Weight: 198.22
  • Density: 1.2 g/cm3
  • Boiling Point : 215 degree C
  • Melting Point: 77-81 degree C
  • Form : Powder

This drug helps loosen congestion in your chest and throat. We are a well-established firm that has made its presence in the industry, by offering Guaifenesin powder. This drug is used to treat coughs and congestion caused by the common cold, bronchitis, and other breathing illnesses. This product is usually not used for ongoing cough from smoking or long-term breathing problems unless directed by doctor. It can be used in combination with dextromethorphan to cough up thick mucus. It can also be used in combination with ephedrine to produce Primatene and Bronkaid tablets to provide symptomatic relief from asthma. It comes as a tablet, a capsule, an extended-release tablet, dissolving granules, and a syrup (liquid) to take by mouth. 

How does it work?


It works by thinning and loosening mucus in the airways, clearing congestion, and making breathing easier. 

Applications. Or where it is used:


Guaifenesin treats coughs and congestion caused by bronchitis, colds, and other respiratory conditions. In general, this product is not recommended for coughing from smoking, chronic bronchitis, or long-term breathing problems (such as emphysema), unless directed by your physician. It acts as an expectorant.

Dosage of usage:

1) Adult: 100-400 mg orally every 4 hours; not to exceed 2.4 g/day
2) Extended release: 1-2 tablets (600-1200 mg) orally every 12 hours; not to exceed 4 tablets/24 hours (2.4 g/day)
3) Children 6 months to 2 years: 25-50 mg every 4 hours; up to 300 mg/day
4) Children 2-6 years: 50-100 mg orally every 4 hours; up to 600 mg/day
5) Children 6-12 years: 100-200 mg orally every 4 hours; up to 1.2 g/day
6) Children older than 12 years
  • 100-400 mg orally every 4 hours; up to 2.4 g/day, OR
  • 1-2 extended-release tablets (600-1200 mg) orally every 12 hours; not to exceed 4 tablets/24 hours (2.4 g/day)

Side effects:


Guaifenesin Side Effects:
  • Allergic reaction
  • Trouble in breathing
  • Nausea
  • Vomiting
  • Rash
  • Itching
  • Swelling
  • Severe dizziness
  • Headache

It is rare to experience a very serious allergic reaction to this drug. In any case, due to Guaifenesin if you get any kind of reactions in your body try avoiding it.

Precautions:


In case of an allergic reaction, talk to your doctor before taking the Guaifenesin. The medication contains some inactive ingredients that may result in allergic reactions or other serious side effects.

Before you take the medication, let the doctor know about any medical history you have, such as:
  • Breathing problems
  • Emphysema
  • Chronic Bronchitis
  • Asthma
  • Smoker cough
  • Cough with blood and large amounts of mucus.
Tell us about your requirement
product

Price:

Quantity
Select Unit

  • 50
  • 100
  • 200
  • 250
  • 500
  • 1000+
Additional detail
+91
  • India (भारत)+91
  • United Arab Emirates (‫الإمارات العربية المتحدة‬‎)+971
  • United States+1
  • China (中国)+86
  • Afghanistan (‫افغانستان‬‎)+93
  • Albania (Shqipëri)+355
  • Algeria (‫الجزائر‬‎)+213
  • American Samoa+1684
  • Andorra+376
  • Angola+244
  • Anguilla+1264
  • Antigua and Barbuda+1268
  • Argentina+54
  • Armenia (Հայաստան)+374
  • Aruba+297
  • Australia+61
  • Austria (Österreich)+43
  • Azerbaijan (Azərbaycan)+994
  • Bahamas+1242
  • Bahrain (‫البحرين‬‎)+973
  • Bangladesh (বাংলাদেশ)+880
  • Barbados+1246
  • Belarus (Беларусь)+375
  • Belgium (België)+32
  • Belize+501
  • Benin (Bénin)+229
  • Bermuda+1441
  • Bhutan (འབྲུག)+975
  • Bolivia+591
  • Bosnia and Herzegovina (Босна и Херцеговина)+387
  • Botswana+267
  • Brazil (Brasil)+55
  • British Indian Ocean Territory+246
  • British Virgin Islands+1284
  • Brunei+673
  • Bulgaria (България)+359
  • Burkina Faso+226
  • Burundi (Uburundi)+257
  • Cambodia (កម្ពុជា)+855
  • Cameroon (Cameroun)+237
  • Canada+1
  • Cape Verde (Kabu Verdi)+238
  • Caribbean Netherlands+599
  • Cayman Islands+1345
  • Central African Republic (République centrafricaine)+236
  • Chad (Tchad)+235
  • Chile+56
  • China (中国)+86
  • Christmas Island+61
  • Cocos (Keeling) Islands+61
  • Colombia+57
  • Comoros (‫جزر القمر‬‎)+269
  • Congo (DRC) (Jamhuri ya Kidemokrasia ya Kongo)+243
  • Congo (Republic) (Congo-Brazzaville)+242
  • Cook Islands+682
  • Costa Rica+506
  • Côte d’Ivoire+225
  • Croatia (Hrvatska)+385
  • Cuba+53
  • Curaçao+599
  • Cyprus (Κύπρος)+357
  • Czech Republic (Česká republika)+420
  • Denmark (Danmark)+45
  • Djibouti+253
  • Dominica+1767
  • Dominican Republic (República Dominicana)+1
  • Ecuador+593
  • Egypt (‫مصر‬‎)+20
  • El Salvador+503
  • Equatorial Guinea (Guinea Ecuatorial)+240
  • Eritrea+291
  • Estonia (Eesti)+372
  • Ethiopia+251
  • Falkland Islands (Islas Malvinas)+500
  • Faroe Islands (Føroyar)+298
  • Fiji+679
  • Finland (Suomi)+358
  • France+33
  • French Guiana (Guyane française)+594
  • French Polynesia (Polynésie française)+689
  • Gabon+241
  • Gambia+220
  • Georgia (საქართველო)+995
  • Germany (Deutschland)+49
  • Ghana (Gaana)+233
  • Gibraltar+350
  • Greece (Ελλάδα)+30
  • Greenland (Kalaallit Nunaat)+299
  • Grenada+1473
  • Guadeloupe+590
  • Guam+1671
  • Guatemala+502
  • Guernsey+44
  • Guinea (Guinée)+224
  • Guinea-Bissau (Guiné Bissau)+245
  • Guyana+592
  • Haiti+509
  • Honduras+504
  • Hong Kong (香港)+852
  • Hungary (Magyarország)+36
  • Iceland (Ísland)+354
  • India (भारत)+91
  • Indonesia+62
  • Iran (‫ایران‬‎)+98
  • Iraq (‫العراق‬‎)+964
  • Ireland+353
  • Isle of Man+44
  • Israel (‫ישראל‬‎)+972
  • Italy (Italia)+39
  • Jamaica+1876
  • Japan (日本)+81
  • Jersey+44
  • Jordan (‫الأردن‬‎)+962
  • Kazakhstan (Казахстан)+7
  • Kenya+254
  • Kiribati+686
  • Kosovo+383
  • Kuwait (‫الكويت‬‎)+965
  • Kyrgyzstan (Кыргызстан)+996
  • Laos (ລາວ)+856
  • Latvia (Latvija)+371
  • Lebanon (‫لبنان‬‎)+961
  • Lesotho+266
  • Liberia+231
  • Libya (‫ليبيا‬‎)+218
  • Liechtenstein+423
  • Lithuania (Lietuva)+370
  • Luxembourg+352
  • Macau (澳門)+853
  • Macedonia (FYROM) (Македонија)+389
  • Madagascar (Madagasikara)+261
  • Malawi+265
  • Malaysia+60
  • Maldives+960
  • Mali+223
  • Malta+356
  • Marshall Islands+692
  • Martinique+596
  • Mauritania (‫موريتانيا‬‎)+222
  • Mauritius (Moris)+230
  • Mayotte+262
  • Mexico (México)+52
  • Micronesia+691
  • Moldova (Republica Moldova)+373
  • Monaco+377
  • Mongolia (Монгол)+976
  • Montenegro (Crna Gora)+382
  • Montserrat+1664
  • Morocco (‫المغرب‬‎)+212
  • Mozambique (Moçambique)+258
  • Myanmar (Burma) (မြန်မာ)+95
  • Namibia (Namibië)+264
  • Nauru+674
  • Nepal (नेपाल)+977
  • Netherlands (Nederland)+31
  • New Caledonia (Nouvelle-Calédonie)+687
  • New Zealand+64
  • Nicaragua+505
  • Niger (Nijar)+227
  • Nigeria+234
  • Niue+683
  • Norfolk Island+672
  • North Korea (조선 민주주의 인민 공화국)+850
  • Northern Mariana Islands+1670
  • Norway (Norge)+47
  • Oman (‫عُمان‬‎)+968
  • Pakistan (‫پاکستان‬‎)+92
  • Palau+680
  • Palestine (‫فلسطين‬‎)+970
  • Panama (Panamá)+507
  • Papua New Guinea+675
  • Paraguay+595
  • Peru (Perú)+51
  • Philippines+63
  • Poland (Polska)+48
  • Portugal+351
  • Puerto Rico+1
  • Qatar (‫قطر‬‎)+974
  • Réunion (La Réunion)+262
  • Romania (România)+40
  • Russia (Россия)+7
  • Rwanda+250
  • Saint Barthélemy+590
  • Saint Helena+290
  • Saint Kitts and Nevis+1869
  • Saint Lucia+1758
  • Saint Martin (Saint-Martin (partie française))+590
  • Saint Pierre and Miquelon (Saint-Pierre-et-Miquelon)+508
  • Saint Vincent and the Grenadines+1784
  • Samoa+685
  • San Marino+378
  • São Tomé and Príncipe (São Tomé e Príncipe)+239
  • Saudi Arabia (‫المملكة العربية السعودية‬‎)+966
  • Senegal (Sénégal)+221
  • Serbia (Србија)+381
  • Seychelles+248
  • Sierra Leone+232
  • Singapore+65
  • Sint Maarten+1721
  • Slovakia (Slovensko)+421
  • Slovenia (Slovenija)+386
  • Solomon Islands+677
  • Somalia (Soomaaliya)+252
  • South Africa+27
  • South Korea (대한민국)+82
  • South Sudan (‫جنوب السودان‬‎)+211
  • Spain (España)+34
  • Sri Lanka (ශ්‍රී ලංකාව)+94
  • Sudan (‫السودان‬‎)+249
  • Suriname+597
  • Svalbard and Jan Mayen+47
  • Swaziland+268
  • Sweden (Sverige)+46
  • Switzerland (Schweiz)+41
  • Syria (‫سوريا‬‎)+963
  • Taiwan (台灣)+886
  • Tajikistan+992
  • Tanzania+255
  • Thailand (ไทย)+66
  • Timor-Leste+670
  • Togo+228
  • Tokelau+690
  • Tonga+676
  • Trinidad and Tobago+1868
  • Tunisia (‫تونس‬‎)+216
  • Turkey (Türkiye)+90
  • Turkmenistan+993
  • Turks and Caicos Islands+1649
  • Tuvalu+688
  • U.S. Virgin Islands+1340
  • Uganda+256
  • Ukraine (Україна)+380
  • United Arab Emirates (‫الإمارات العربية المتحدة‬‎)+971
  • United Kingdom+44
  • United States+1
  • Uruguay+598
  • Uzbekistan (Oʻzbekiston)+998
  • Vanuatu+678
  • Vatican City (Città del Vaticano)+39
  • Venezuela+58
  • Vietnam (Việt Nam)+84
  • Wallis and Futuna (Wallis-et-Futuna)+681
  • Western Sahara (‫الصحراء الغربية‬‎)+212
  • Yemen (‫اليمن‬‎)+967
  • Zambia+260
  • Zimbabwe+263
  • Åland Islands+358
Mobile number

Email

Other Products in 'Active Pharmaceuticals Ingredients (API)' category